当前位置:首页 - 行情中心 - 春立医疗(688236) - 财务分析 - 现金流量表

春立医疗

(688236)

  

流通市值:41.04亿  总市值:54.58亿
流通股本:2.88亿   总股本:3.84亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金377,757,473.92141,900,211.931,162,512,413.23787,304,954.6
  收到的税费返还--2,825,763.952,825,763.95
  收到其他与经营活动有关的现金15,710,516.496,027,991.2752,637,106.3315,765,417.63
  经营活动现金流入小计393,467,990.41147,928,203.21,217,975,283.51805,896,136.18
  购买商品、接受劳务支付的现金127,937,374.7967,926,712.43375,083,907.55298,567,305.53
  支付给职工以及为职工支付的现金102,875,370.5245,064,602.87187,210,571.05149,971,256.13
  支付的各项税费46,452,984.3113,613,723.3447,771,951.1729,932,778.5
  支付其他与经营活动有关的现金81,880,247.0732,251,218.99203,068,928.66152,857,751.91
  经营活动现金流出小计359,145,976.69158,856,257.63813,135,358.43631,329,092.07
  经营活动产生的现金流量净额34,322,013.72-10,928,054.43404,839,925.08174,567,044.11
二、投资活动产生的现金流量:
  收回投资收到的现金790,000,000-1,689,000,000744,000,000
  取得投资收益收到的现金7,648,931.51-15,609,166.866,619,109.04
  处置固定资产、无形资产和其他长期资产收回的现金净额2,838-23,00023,000
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计797,651,769.51-1,704,632,166.86750,642,109.04
  购建固定资产、无形资产和其他长期资产支付的现金27,561,388.9819,994,053.259,127,974.3548,492,401.83
  投资支付的现金725,000,000-1,755,000,000880,000,000
  取得子公司及其他营业单位支付的现金--2,200,0002,200,000
  投资活动现金流出小计752,561,388.9819,994,053.21,816,327,974.35930,692,401.83
  投资活动产生的现金流量净额45,090,380.53-19,994,053.2-111,695,807.49-180,050,292.79
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金104,885,018.2880,249,991.7418,727,390.818,727,390.8
  支付其他与筹资活动有关的现金2,065,955.471,159,250.2110,787,049.438,656,570.63
  筹资活动现金流出小计106,950,973.7581,409,241.9529,514,440.2327,383,961.43
  筹资活动产生的现金流量净额-106,950,973.75-81,409,241.95-29,514,440.23-27,383,961.43
四、汇率变动对现金及现金等价物的影响-537,020.27-320,760.32-174,841.04-248,760.77
五、现金及现金等价物净增加额-28,075,599.77-112,652,109.9263,454,836.32-33,115,970.88
  加:期初现金及现金等价物余额1,402,472,486.981,402,472,486.981,139,017,650.661,139,017,650.66
  期末现金及现金等价物余额1,374,396,887.211,289,820,377.081,402,472,486.981,105,901,679.78
补充资料:
  净利润119,938,952.22-272,625,119.37-
  资产减值准备6,043,562.98-37,239,267.09-
  固定资产和投资性房地产折旧14,564,846.6-27,072,361.18-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧14,564,846.6-27,072,361.18-
  无形资产摊销4,828,907.31-12,503,614.76-
  处置固定资产、无形资产和其他长期资产的损失---3,848.03-
  固定资产报废损失-47,000.94---
  公允价值变动损失-3,648,527.39--8,742,663-
  财务费用613,766.96-213,991.25-
  投资损失-2,818,027.41--6,315,413.45-
  递延所得税-485,291.03--2,488,546.87-
  其中:递延所得税资产减少927,372.34--4,223,349.73-
    递延所得税负债增加-1,412,663.37-1,734,802.86-
  存货的减少2,349,517.71--22,322,048.59-
  经营性应收项目的减少-28,594,465.41-120,414,618.12-
  经营性应付项目的增加-80,876,277.24--37,285,223.07-
  现金的期末余额1,374,396,887.21-1,402,472,486.98-
  减:现金的期初余额1,402,472,486.98-1,139,017,650.66-
  现金及现金等价物的净增加额-28,075,599.77-263,454,836.32-
公告日期2026-08-292026-04-302026-03-312025-10-31
审计意见(境内)标准无保留意见
TOP↑